Aemetis, Inc. operates as an international renewable fuels and specialty chemical company. The company focuses on the production of advanced fuels and chemicals; and the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products and convert first-generation ethanol and biodiesel plants into advanced biorefineries. Segments The company operates in two geographic segments, North America and India. North America This segment owns and operates a 55 million gallon per year ethanol production facility located in Keyes, California. The facility produces its own combined heat and power through the use of a natural gas-powered steam turbine, and reuses 100% of its process water with no water discharge. In addition to ethanol, the Keyes plant produces wet distillers grains (WDG), corn oil, and condensed distillers solubles, all of which are sold to local dairies and feedlots for animal consumption. Customers: All of the company’s ethanol and WDG are sold to J.D. Heiskell pursuant to a purchase agreement. J.D. Heiskell in turn sells all of the company’s ethanol to Kinergy and all of the company’s WDG to A.L. Gilbert. Kinergy markets and sells the company’s ethanol to petroleum refiners and blenders in Northern California. A.L. Gilbert markets and sells the company’s WDG to approximately 200 dairy and feeding operators in Northern California. Strategy: Major elements of the company’s strategy are to leverage approved feedstock pathways; leverage the Keyes plant infrastructure and location; leverage technology for the development and production of additional advanced biofuels and renewable specialty chemicals; continue to develop value-add byproduct processing systems and processes; and evaluate and pursue technology acquisition opportunities. India This segment owns and operates a biodiesel production facility in Kakinada, India with a nameplate capacity of 150,000 metric tons per year. Sales and Marketing: The company sells its biodiesel and crude glycerin to end-users utilizing its own sales force and independent sales agents; and to brokers who resell the product to end-users. Strategy: Major elements of the company’s strategy are to capitalize on actions by the Government of India to reduce the subsidies on diesel; expand alternative market demand for biodiesel and its byproducts; continue to develop international markets; and diversify its feedstocks and products. Competition: This segment competes with Indian Oil Corporation, Bharat Petroleum, Hindustan Petroleum, Reliance Petroleum, and Essar Oil. Research and Development The company’s research and development expense was $538,922 in 2013. Its research and development efforts consist of working to commercialize its existing microbial technology, to evaluate third party technologies, and to expand the production of ethanol and other renewable bio-chemicals in the United States. Patents and Trademarks The company holds eight patents and has applied for six additional patents in the United States. Its patents cover the Z-microbe and production of cellulosic ethanol. Environmental and Regulatory Matters The company’s air emissions are subject to the federal Clean Air Act, and similar state laws, which require the company to obtain and maintain air emission permits for its ongoing operations, as well as for any expansion of existing facilities or any new facilities. History The company was founded in 2005. It was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in 2011. The company was incorporated in Nevada in 2006.
aemetis inc (AMTX:NASDAQ GM)
20400 Stevens Creek Boulevard
Cupertino, CA 95014
|Amyris Inc||$2.07 USD||+0.05|
|China Clean Energy Inc||$0.03 USD||0.00|
|Gevo Inc||$3.02 USD||-0.20|
|Granite Falls Energy LLC||$3,000 USD||0.00|
|Sino Clean Energy Inc||$0.18 USD||0.00|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact AEMETIS INC, please visit www.aemetis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.